A U.S. jury on Tuesday found Bayer AG’s glyphosate-based weed killer to be a “substantial factor” in causing a man’s non-Hodgkin’s lymphoma, allowing the trial to proceed into a second phase on liability and damages.
Latest posts by Reuters News (see all)
- Exclusive: U.S. carves out exceptions for foreigners dealing with IRGC - April 21, 2019
- Khamenei names new chief for Iran’s Revolutionary Guards - April 21, 2019
- Saudi Arabia, UAE to send $3 billion in aid to Sudan - April 21, 2019